glp-1compoundpharmacy

The formulation archive
Independent editorial information · not individual medical advice

Commercial pages may contain paid referral links. Compare the full payment terms and licensed-care details before enrollment.

This page contains affiliate links. We may earn a commission if you sign up through them, at no cost to you. All recommendations are independent.

Why Your Compounded Vial Volume Changed This Refill

You open this month's shipment and something's off. The vial is smaller. Or larger. Or the same size but with a different fill line. Your prescription hasn't changed. What happened?

Concentration Changes Explained

Compounded GLP-1s are prepared at a specific concentration — for semaglutide, common concentrations include 2.5 mg/mL, 5 mg/mL, and (less commonly) higher. The concentration is chosen by the compounding pharmacy for practical reasons: draw volumes that patients can handle, vial capacity, dose flexibility, and stability of the compounded solution.

If the pharmacy changes concentration between refills — for example, moving from 2.5 mg/mL to 5 mg/mL — the total volume you receive for the same weekly dose will change. Half the concentration change means half the volume for the same dose.

Why Pharmacies Change Concentration

Pharmacies change concentration for legitimate reasons: better shipping stability at a different concentration, dose flexibility for patients on custom titration, alignment with a new formulation base, or in some cases a switch that saves the pharmacy on filling operations. None of these are inherently bad — but the change should always come with clear communication to the patient about the new draw volume.

Embody

Injectable semaglutide — pricing varies

Injectable semaglutide only; a lead compounded-injectable option.

  • Injectable semaglutide focus
  • Standard 12-week titration
  • Direct-to-patient pharmacy shipping
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →
Sponsored partner · Compounded and branded pathwaysGobyMeds

Explore the program’s treatment pathways and ask which medication type, pharmacy, enrollment requirements and recurring charges apply to your location.

Explore GobyMeds ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.

Recalculating Your Draw Volume

Your prescription is written for a specific dose in milligrams (e.g., 0.5 mg weekly). The concentration on the vial label tells you how many milligrams are in each milliliter. Divide your dose by the concentration to get the volume to draw.

Example: If your prescription is 0.5 mg weekly and the new vial is 5 mg/mL, you draw 0.5 ÷ 5 = 0.1 mL. If the previous vial was 2.5 mg/mL, you were drawing 0.5 ÷ 2.5 = 0.2 mL. Same dose, half the draw volume on the new concentration.

Never assume the draw volume is the same as last month. Read the current vial label every time.

Sponsored partner · Weight-management telehealthOak GLP-1

Review current treatment pathways, screening and follow-up, and clarify which medication and monthly charges apply.

Explore Oak GLP-1 ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.
SPONSORED CARE OPTION

Sesame

Compare licensed-clinician services and ask about pharmacy sourcing, FDA-approved treatment options and itemized charges. Compounded medicines are not FDA-approved.

Pricing, medication access, service area and plan terms must be confirmed with the provider. This is not a drug-specific checkout link.

Explore Sesame program ↗

When to Contact the Pharmacy

Contact the pharmacy immediately if: the vial arrives without a concentration label; the concentration on the label doesn't match your prescription record; the fill volume looks visibly different from expected for your prescribed concentration; or the pharmacy didn't notify you of a change and you're seeing one.

Well-run pharmacies handle these questions quickly and can walk you through the correct draw volume in a short call.

MadeMed

Oral tirzepatide ~$229/mo

Independent compounder offering compounded oral tirzepatide.

  • Compounded oral tirzepatide
  • $167–$229 range per dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →
Sponsored partner · Compounded tirzepatide listingHealthRX — tirzepatide

Explore HealthRX’s compounded tirzepatide listing. Compounded medications are not FDA-approved; verify the current legal pathway, pharmacy and total price.

Explore HealthRX — tirzepatide ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.

Don't Guess

The single most important rule with concentration changes: don't guess. A concentration change looks small on the label but represents a real dose-math change. Confirm the correct volume before drawing your first dose from a new vial. Most dosing errors from compounded GLP-1s trace back to unrecognized concentration changes, not to bad medication.

Where to Start

Embody

Injectable semaglutide — pricing varies

Injectable semaglutide only; a lead compounded-injectable option.

  • Injectable semaglutide focus
  • Standard 12-week titration
  • Direct-to-patient pharmacy shipping
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →

MadeMed

Oral tirzepatide ~$229/mo

Independent compounder offering compounded oral tirzepatide.

  • Compounded oral tirzepatide
  • $167–$229 range per dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →

SHED

Starts lower, $399/mo at 7.5mg+

Note: SHED's price jumps to $399/mo once you titrate to 7.5mg or higher.

  • Lower entry pricing
  • Price jump at 7.5mg+
  • Compounded semaglutide + tirzepatide
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →